J&J Signs $990M Crohn’s Drug Deal with Protagonist Therapeutics
30 May 2017 //
PHARMAMANUFACTURING
Protagonist Therapeutics Initiates Phase 1 Study with Oral Peptide PTG-100
06 Jan 2016 //
PR NEWSWIRE
30 May 2017 //
PHARMAMANUFACTURING
06 Jan 2016 //
PR NEWSWIRE